Welcome to the all-new Vetlearn

  • Vetlearn is getting a new home. Starting this fall,
    Vetlearn becomes part of the NAVC VetFolio family.

    You'll have access to the entire Compendium and
    Veterinary Technician archives and get to explore
    even more ways to learn and earn CE by becoming
    a VetFolio subscriber. Subscriber benefits:
  • Over 500 hours of interactive CE Videos
  • An engaging new Community for tough cases
    and networking
  • Three years of NAVC Conference Proceedings
  • All-new articles (CE and other topics) for the entire
    healthcare team

To access Vetlearn, you must first sign in or register.

registernow

  • Registration for new subscribers will open in September 2014!
  • Watch for additional exciting news coming soon!
Become a Member

Veterinary Forum July 2009 (Vol 26, No 7)

Putney develops generic NSAID

    PORTLAND, Maine — Putney, a pharmaceutical company focused on the development of generic drugs for pets, has launched carprofen caplets, a bioequivalent generic version of the canine medication Rimadyl (Pfizer Animal Health) caplets.

    Carprofen is widely used in dogs for the relief of pain and inflammation associated with osteoarthritis, as well as the control of postoperative pain associated with soft tissue and orthopedic surgeries.

    Putney's carprofen caplets have demonstrated bioequivalence to Rimadyl caplets in an FDA-approved study and will be available in 25-mg, 75-mg and 100-mg caplets.

    For more information, visit www.putneyvet.com.

    NEXT: Reader Forum (July 2009)

    didyouknow

    Did you know... Because chemotherapeutic agents consistently suppress hematopoiesis, their administration should be monitored with periodic complete blood counts.Read More

    These Care Guides are written to help your clients understand common conditions. They are formatted to print and give to your clients for their information.

    Stay on top of all our latest content — sign up for the Vetlearn newsletters.
    • More
    Subscribe